ERBB2 and neoplasm: Reduced TUNEL staining and reduced tumor-free survival was reported in Hsf1+/+ Neu+ experimental tumors compared to Hsf1+/− Neu+, indicating higher rates of apoptosis in Hsf1+/− tumors [63].